BIOMAT Database Logo BIOMAT Database Logo

Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate. 2017

Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, 264005, People's Republic of China.

A bifunctional RGDTAT peptide-modified PEG-PAMAM dendrimer conjugate RGDTAT-PEG-PAMAM (RTPP) was established for the targeted treatment of αvβ3-overexpressing tumor cells. The RGDTAT peptide was synthesized and attached to PAMAM using PEG to construct the RTPP conjugate. The methotrexate (MTX) encapsulated RTPPM complex was prepared and characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM) and in vitro release. The targeting ability was then studied in cells and tumor-bearing nude mice using fluorescence microscopy, confocal fluorescence microscopy, flow cytometry, and in vivo imaging. The cytotoxicity and pharmacokinetics of the RTPPM complex was also evaluated in cells and rats. The successful synthesis of the RTPP conjugate was confirmed by 1H-NMR. DLS and TEM measurements revealed that the size was 37 nm and the complex had a spherical shape. RTPP and RTPPM were taken up by αvβ3-overexpressing cells more efficiently than by αvβ3-lowexpressing cells. The RTPP conjugate localized to the cell nucleus and accumulated in the tumor more efficiently than did the conjugates without RGDTAT. The pharmacokinetic study of the RTPPM complex showed sustained drug release. The bifunctional peptide-mediated dendrimer-based RTPP conjugate can serve as a promising nanocarrier for targeted drug delivery to improve anti-tumor activity.

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Molecular simulation studies on a zwitterionic peptide-dendrimer conjugate for integrin αvβ3 binding.
May 2023, Biointerphases,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
January 2018, International journal of nanomedicine,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Novel peptide targeting integrin αvβ3-rich tumor cells by magnetic resonance imaging.
August 2011, Journal of magnetic resonance imaging : JMRI,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy.
January 2022, Frontiers in oncology,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
December 2015, International journal of pharmaceutics,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αVβ3.
January 2022, Frontiers in chemistry,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Dendrimer-based tumor cell targeting of fibroblast growth factor-1.
January 2010, Bioorganic & medicinal chemistry letters,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment.
March 2021, European journal of medicinal chemistry,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Dual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-Penetrating Peptide.
August 2016, Journal of the American Chemical Society,
Pengkai Ma, and Huajun Yu, and Xuemei Zhang, and Hongjie Mu, and Yongchao Chu, and Ling Ni, and Pingping Xing, and Yiyun Wang, and Kaoxiang Sun
Receptor-mediated tumor targeting based on peptide hormones.
January 2010, Expert opinion on drug delivery,
Copied contents to your clipboard!